Yoshiharu Tsubakihara

Yoshiharu Tsubakihara

Auto-generated profile, based on publicly available information

Yoshiharu Tsubakihara

Committee of Renal Data Registry Japanese Society for Dialysis Therapy Tokyo Japan

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in Kidney International
Verified
Journal Article
Closed access
PDF file
TSTatsuya Shoji
Tatsuya Shoji
YTYoshiharu Tsubakihara
Yoshiharu Tsubakihara
MFMasamitsu Fujii
Masamitsu Fujii
EIEnyu Imai
Enyu Imai

25 May 2010 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
YTYoshiharu Tsubakihara
Yoshiharu Tsubakihara
SNShinichi Nishi
Shinichi Nishi
TATakashi Akiba
Takashi Akiba
HHHideki Hirakata
Hideki Hirakata
KIKunitoshi Iseki
Kunitoshi Iseki
TATadao Akizawa
Tadao Akizawa

1 February 2000 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
THTerumasa Hayashi
Terumasa Hayashi
ASAkira Suzuki
Akira Suzuki
TSTatsuya Shoji
Tatsuya Shoji
MTMasaki Togawa
Masaki Togawa
NONoriyuki Okada
Noriyuki Okada
MHMasatsugu Hori
Masatsugu Hori

30 November 2010 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Open access
PDF file
SNShigeru Nakai
Shigeru Nakai
KSKazuyuki Suzuki
Kazuyuki Suzuki
IMIkuto Masakane
Ikuto Masakane
AWAtsushi Wada
Atsushi Wada
NINoritomo Itami
Noritomo Itami
YTYoshiharu Tsubakihara
Yoshiharu Tsubakihara
A nationwide statistical survey of 4124 dialysis facilities was conducted at the end of 2008 and 4081 facilities (99.0%) responded. The number of patients undergoing dialysis at the end of 2008 was determined to be 283 421, an increase of 8179 patients (3.0%) compared with that at the end of 2007. The number of dialysis patients per million at the end of 2008 was 2220. The crude death rate of dialysis patients from the end of 2007 to the end of 2008 was 9.8%. The mean age of the new patients begun on dialysis was 67.2 years and the mean age of the entire dialysis patient population was 65.3 years. For the primary diseases of the new patients begun on dialysis, the percentages of patients with diabetic nephropathy and chronic glomerulonephritis were 43.3% and 22.8%, respectively. Among the facilities that measured bacterial count in the dialysate solution in 2008, 52.0% of facilities ensured that a minimum dialysate solution volume of 10 mL was sampled. Among the patients treated by facility dialysis, 95.4% of patients were treated three times a week, and the average time required for one treatment was 3.92 ± 0.53 (SD) h. The average amounts of blood flow and dialysate solution flow were 197 ± 31 and 487 ± 33 mL/min, respectively. The number of patients using a polysulfone membrane dialyzer was the largest (50.7%) and the average membrane area was 1.63 ± 0.35 m2. According to the classification of dialyzers by function, the number of patients using a type IV dialyzer was the largest (80.3%). The average concentrations of each electrolyte before treatment in patients treated with blood purification by extracorporeal circulation were 138.8 ± 3.3 mEq/L for serum sodium, 4.96 ± 0.81 mEq/L for serum potassium, 102.1 ± 3.1 mEq/L for serum chloride, and 20.7 ± 3.0 mEq/L for HCO3‐; the average serum pH was 7.35 ± 0.05. Regarding the type of vascular access in patients treated by facility dialysis, in 89.7% of patients an arteriovenous fistula was used and in 7.1% an arteriovenous graft was used. The percentage of hepatitis C virus (HCV)‐positive patients who were HCV‐negative in 2007 was 1.04%; the percentage is particularly high in patients with a period of dialysis of 20 years or longer. The risk of becoming HCV‐positive was high in patients with low serum creatinine, serum albumin, and serum total cholesterol levels, and/or a low body mass index before beginning dialysis.

18 December 2014 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
SNShigeru Nakai
Shigeru Nakai
NHNorio Hanafusa
Norio Hanafusa
IMIkuto Masakane
Ikuto Masakane
MTMasatomo Taniguchi
Masatomo Taniguchi
THTakayuki Hamano
Takayuki Hamano
YTYoshiharu Tsubakihara
Yoshiharu Tsubakihara

10 October 2012 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Open access
PDF file
HHHideki Hirakata
Hideki Hirakata
KNKosaku Nitta
Kosaku Nitta
MIMasaaki Inaba
Masaaki Inaba
TSTetsuo Shoji
Tetsuo Shoji
HFHideki Fujii
Hideki Fujii
TATadao Akizawa
Tadao Akizawa